Authors: VRIEILING C COLLETTE L FOURQUET A HOOGENRAAD WJ HORIOT JC JAGER JJ PETERSE JL PIERART M POORTMANS PM STRUIKMANS H VANDERSCHUEREN E BARTELINK H

Citation: C. Vrieiling et al., THE INFLUENCE OF THE BOOST ON THE COSMETIC OUTCOME AFTER BREAST-CONSERVING THERAPY, European journal of cancer, 34, 1998, pp. 254-254

Authors: VRIELING C COLLETTE L FOURQUET A HOOGENRAAD WJ HORIOT JC JAGER JJ PETERSE JL PIERART M POORTMANS PM STRUIKMANS H VANDERSCHUEREN E BARTELINK H

Citation: C. Vrieling et al., THE HIGHER LOCAL RECURRENCE RATE AFTER BREAST-CONSERVING THERAPY IN YOUNG-PATIENTS EXPLAINED BY LARGER TUMOR SIZE, INCOMPLETE EXCISION AT FIRST ATTEMPT AND SMALLER EXCISION VOLUME, European journal of cancer, 34, 1998, pp. 444-444

Authors: WAGENER DJT HOOGENRAAD WJ ROUGIER P LUSINCHI A TAAL BG VEENHOF CHN DEGRAEFF A CONROY T CURRAN D SAHMOUD T WILS J

Citation: Djt. Wagener et al., RESULTS OF A PHASE-II TRIAL OF EPIRUBICIN AND CISPLATIN (EP) BEFORE AND AFTER IRRADIATION AND 5-FLUOROURACIL IN LOCALLY ADVANCED PANCREATIC-CANCER - AN EORTC GITCCG STUDY, European journal of cancer, 32A(8), 1996, pp. 1310-1313

Authors: PTASZYNSKI A VANDENBOGAERT W VANGLABBEKE M PIERART M BARTELINK H HORIOT JC FOURQUET A STRUIKMANS H HAMERS H MULLER RP HOOGENRAAD WJ JAGER JJ VANDERSCHUEREN E

Citation: A. Ptaszynski et al., PATIENT POPULATION ANALYSIS IN EORTC TRIAL-22881 10882 ON THE ROLE OFA BOOSTER DOSE IN BREAST-CONSERVING THERAPY/, European journal of cancer, 30A(14), 1994, pp. 2073-2081

Authors: JANSSENS PJP WAGENER DJT NAGENGAST FM HOOGENRAAD WJ WOBBES T JOOSTEN HJM OEI SB VANDERSTEENBANASIK EM

Citation: Pjp. Janssens et al., RESULTS OF TREATMENT OF THE ADENOCARCINOMA OF THE ESOPHAGUS, Anticancer research, 13(1), 1993, pp. 209-214